Mutations given The point that, as described below, CLL therapy is based on the presence or absence of those mutations. The current consensus is usually that, besides clonal mutations, subclonal mutations having a variant allelic frequency ranging from five to ten% (and as a consequence underneath the edge of detection https://cassa090rjb0.blogthisbiz.com/profile